Screener
Bicara Therapeutics BCAX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
FAQ
- What is Bicara Therapeutics's free cash flow?
- Bicara Therapeutics (BCAX) reported free cash flow of -$37.57M in Q1 2026.
- How has Bicara Therapeutics's free cash flow changed year-over-year?
- Bicara Therapeutics's free cash flow decreased by 33.7% year-over-year, from -$28.11M to -$37.57M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Bicara Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude